Table B2. Congressional Budget Justification Sexually Transmitted Diseases Goals, Measures, and Target
|Congressional Budget Justification Goals||Actual||Target|
|Contextual Indicators||2.7.6e. Proportion of sexually active females aged 16–24 years enrolled in Medicaid who are screened for chlamydia infections||60.0%||60.7%*||N/A||60.0%|
|2.7.6f. Proportion of sexually active females aged 16–24 years enrolled in commercial health insurance plans who are screened for chlamydia infections||50.1%||51.5%*||N/A||50.1%|
|2.7.7. Reduce the rate† of symptomatic gonorrhea cases in men||146.1||148.3||173.4||148.3|
|Performance Measures for Long Term Objective: Reduce Pelvic Inflammatory Disease in the U.S.||2.7.5. Increase the proportion of gonorrhea patients who are treated with a CDC-recommended antibiotic regimen for gonorrhea||81.3%||82.4%||85.8%||87.6%|
|2.9.1. Reduce the incidence of P&S syphilis/100,000 population in women aged 15–44||4.2||5.1||6.9||0.8|
|2.9.2. Reduce the incidence of congenital syphilis/100,000 live births||15.7||23.3||33.1||6.2|
|2.9.3. Increase the percentage of pregnant women that are screened for syphilis at least one month before delivery||89.5%||89.9%||N/A||87.2%|
|2.9.4. Increase the proportion of potential congenital syphilis cases averted||75.0%||72.0%||N/A||75.0%|
|2.9.5. Reduce the rate of increase of P&S syphilis||18.0%||11.0%||15.0%||9.0%|
|2.7.6e, 2.7.6f||Healthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA)|
|2.7.5, 2.7.7||STD Surveillance Network (SSuN), CDC|
|2.9.1, 2.9.2, 2.9.4, 2.9.5||National Notifiable Disease Surveillance System (NNDSS), CDC|
|2.9.3||MarketScan Commercial Claims and Encounters Database, Truven Health Analytics|
P&S = primary and secondary.
* Proportion based on average screening coverage across plans, weighted by the number of sexually-active women in each plan.
† Per 100,000.
Page last reviewed: September 30, 2019